CONMED Corp (CNMD) Financial Statements
Industry: Electromedical & Electrotherapeutic Apparatus
In fiscal 2025, CONMED reported revenue of $1.37B, up 5.2% from $1.31B the year before. Net income was $47.1M (a 3.4% net margin), or $1.51 per diluted share. Gross margin was 54.6% and operating margin was 7.5%. Operating activities generated $170.7M of cash, leaving $150.9M of free cash flow. At fiscal year end, CONMED held $2.33B in total assets against $1.29B in total liabilities.
Open the full interactive CONMED financials → Quarterly statements, key ratios, valuation history and price charts.
CONMED Key Stats
| Share Price | $45.55 |
|---|---|
| Market Cap | $1.37B |
| P/E Ratio | 30.2 |
| Revenue YoY Growth | +5.2% |
| 52-Week Range | $32.11 – $51.86 |
| Shares Outstanding | 30.1 million (basic, 2026 Q2) |
CONMED Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $862.5M | $1.01B | $1.05B | $1.24B | $1.31B | $1.37B |
| Cost of Goods Sold | $402.2M | $442.6M | $474.2M | $568.5M | $574.0M | $624.2M |
| Gross Profit | $460.3M | $568.0M | $571.2M | $676.2M | $733.0M | $750.5M |
| Operating Income | $46.0M | $109.7M | $70.1M | $120.6M | $200.3M | $102.6M |
| Pre-Tax Income | $1.6M | $73.1M | -$70.9M | $80.8M | $163.0M | $71.1M |
| Income Tax | -$7.9M | $10.6M | $9.7M | $16.4M | $30.6M | $24.1M |
| Net Income | $9.5M | $62.5M | -$80.6M | $64.5M | $132.4M | $47.1M |
| Diluted EPS | $0.32 | $1.94 | -$2.68 | $2.04 | $4.25 | $1.51 |
CONMED Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $337.9M | $373.2M | $317.0M | $343.5M |
| Net Income | $2.9M | $16.7M | $13.8M | $23.1M |
| Diluted EPS | $0.09 | $0.54 | $0.45 | $0.77 |
CONMED Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Current Assets | $416.7M | $460.1M | $581.2M | $615.6M | $640.0M | $672.9M |
| Total Assets | $1.75B | $1.77B | $2.30B | $2.30B | $2.31B | $2.33B |
| Current Liabilities | $190.2M | $196.6M | $296.6M | $310.7M | $278.1M | $315.0M |
| Total Long-Term Debt | $753.6M | $684.7M | $1.05B | $973.8M | $905.8M | $834.9M |
| Total Liabilities | $1.04B | $980.6M | $1.55B | $1.47B | $1.34B | $1.29B |
| Shareholders' Equity | $709.0M | $785.4M | $745.5M | $834.2M | $962.7M | $1.03B |
CONMED Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $64.5M | $111.8M | $33.4M | $125.3M | $167.0M | $170.7M |
| Cash From Investing | -$13.6M | -$14.9M | -$249.5M | -$20.0M | -$13.1M | -$21.0M |
| Cash From Financing | -$52.1M | -$101.5M | $225.0M | -$110.4M | -$151.0M | -$135.8M |
| Free Cash Flow | $51.5M | $96.9M | $11.6M | $106.3M | $153.9M | $150.9M |
Figures from CONMED's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full CONMED financials page for every line item.
CONMED Company Profile
| Ticker | CNMD |
|---|---|
| Exchange | NYSE |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Headquarters | Largo, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000816956 |
Frequently Asked Questions
What was CONMED's revenue in fiscal 2025?
CONMED (CNMD) reported revenue of $1.37B for fiscal 2025.
What is CONMED's annual revenue history?
CONMED's annual revenue by fiscal year: 2020: $862.5M; 2021: $1.01B; 2022: $1.05B; 2023: $1.24B; 2024: $1.31B; 2025: $1.37B.
What was CONMED's net income in fiscal 2025?
CONMED reported net income of $47.1M for fiscal 2025.
What was CONMED's earnings per share (EPS) in fiscal 2025?
CONMED's diluted EPS was $1.51 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did CONMED generate in fiscal 2025?
CONMED generated $150.9M of free cash flow in fiscal 2025.
What was CONMED's revenue last quarter?
In its most recent reported quarter (2026 Q2), CONMED reported revenue of $343.5M.
How much debt does CONMED have?
CONMED reported $834.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of CONMED are outstanding?
CONMED reported a weighted average of 30.1 million basic shares outstanding in 2026 Q2.
What is CONMED's market cap?
Based on its latest closing price, CONMED (CNMD) has a market capitalization of about $1.37B.
When does CONMED's fiscal year end?
CONMED's fiscal year end, as registered with the SEC, is December 31.
Where is CONMED headquartered?
CONMED lists its business address in Largo, Florida in its SEC filings.